Ana Paula Monteiro Gomides

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry

Cláudia Diniz Lopes Marques, Adriana María Kakehasi, Marcelo Medeiros Pinheiro et al. · RMD Open · 2021 · 79 citations · Full text

Life Sciences, Clinical Sciences, Immunology +12

2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis

Lícia Maria Henrique da Mota, Adriana María Kakehasi, Ana Paula Monteiro Gomides et al. · Advances in Rheumatology · 2018 · 49 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Sensorineural dysacusis in patients with systemic lupus erythematosus

Ana Paula Monteiro Gomides, Eduardo José do Rosário, Harald Borges et al. · Lupus · 2007 · 43 citations

Medicine, Audiology, Immunology +15

High Levels of Polypharmacy in Rheumatoid Arthritis—A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study

Ana Paula Monteiro Gomides, Cleandro Pires de Albuquerque, Ana Beatriz Vargas‐Santos et al. · Journal of Pharmacy Practice · 2019 · 39 citations

Medicine, Internal Medicine, Pharmacotherapy +17